Research Topics
Species | Hermann ReichenspurnerSummaryAffiliation: University of Hamburg Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Overview of tacrolimus-based immunosuppression after heart or lung transplantationHermann Reichenspurner
Department of Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
J Heart Lung Transplant 24:119-30. 2005..In particular, the lesser propensity of tacrolimus to cause hypertension and hyperlipidemia potentially offers decreased cardiovascular risk for heart and lung transplant recipients...
Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprosthesesMoritz Seiffert
Department of Cardiovascular Surgery, University Heart Center Hamburg, Germany
J Thorac Cardiovasc Surg 143:617-24. 2012..Nevertheless, hemodynamic performance is limited by the previously implanted xenograft. We report our experience with patient-prosthesis mismatch (PPM) after valve-in-valve implantation in the aortic position...
Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprosthesesMoritz Seiffert
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
JACC Cardiovasc Interv 5:341-9. 2012..This study reports the results of a series of transapical mitral valve-in-valve implantations and aims to offer guidance on technical aspects of the procedure...
Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valveHendrik Treede
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
J Thorac Cardiovasc Surg 140:897-903. 2010..The Direct Flow Medical aortic valve (Direct Flow Medical, Inc, Santa Rosa, Calif) is a nonmetallic tissue valve prosthesis intended to treat patients with severe aortic stenosis at high risk for surgery...
FK778 in experimental xenotransplantation: a detailed analysis of drug efficacySonja Schrepfer
University Heart Center, University Hospital Hamburg Eppendorf, Hamburg, Germany
J Heart Lung Transplant 26:70-7. 2007..This study examines the efficacy of FK778 regimens for prevention of different phases of xenograft rejection...
Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway diseaseTobias Deuse
Department of Cardiovascular Surgery, University Heart Center, University Hospital Hamburg-Eppendorf, Martinistr, Germany
Transpl Int 19:310-8. 2006..The anti-proliferative potency on SMCs seems to be an especially important mechanism for FK778. De novo combination regimens revealed no beneficial interaction and thus remain doubtful...
Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?Sonja Schrepfer
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
Cardiology 108:128-37. 2007..To investigate the efficacy of the malononitrilamide FK778 to prevent vascular smooth muscle cell (SMC) migration/proliferation, and vascular fibrosis, the key events in restenosis development using in vivo and in vitro studies...
FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survivalSonja Schrepfer
Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany
Transpl Int 18:215-20. 2005..Therefore, FK778 is a novel, highly desirable immunosuppressive drug for transplantation medicine...
Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical riskLenard Conradi
Department of Cardiovascular Surgery, University Heart Center Hamburg, University Medical Center Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
Eur J Cardiothorac Surg 40:1521-6. 2011..We report our experience with failed MitraClip™ therapy and its impact on subsequent surgical strategies, such as the feasibility of MVR in high-risk patients...
FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantationTobias Deuse
Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
J Heart Lung Transplant 24:1844-54. 2005..The anti-proliferative potency of FK778 on SMC may be an important mechanism of action. Combination regimens showed favorable drug interaction and allowed dose reduction of both agents to achieve maximal immunosuppressive efficacy...
A heart team's perspective on interventional mitral valve repair: percutaneous clip implantation as an important adjunct to a surgical mitral valve program for treatment of high-risk patientsHendrik Treede
Department of Cardiovascular Surgery, University Heart Center, Hamburg, Germany
J Thorac Cardiovasc Surg 143:78-84. 2012..We sought to assess the feasibility of catheter-based mitral valve repair using a clip-based percutaneous edge-to-edge repair system in selected patients at high surgical risk with mitral regurgitation grade 3 or worse...
The phytoestrogen biochaninA weakens acute cardiac allograft rejection without affecting the reproductive systemSonja Schrepfer
Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
Transpl Immunol 15:45-53. 2005....
Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral positionMoritz Seiffert
Department of Cardiovascular Surgery, University Heart Center Hamburg, Germany
Catheter Cardiovasc Interv 76:608-15. 2010..We report our experience with transcatheter valve-in-valve implantations in patients with degenerated bioprostheses in aortic and mitral position...
Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgeryVolker Rudolph
Department of General and Interventional Cardiology, University Heart Center, University Medical Center Hamburg Eppendorf, Hamburg, Germany
J Am Coll Cardiol 58:2190-5. 2011..The aim of this study was to assess the outcomes of patients at prohibitive surgical risk undergoing MitraClip therapy (Abbott Vascular, Redwood City, California) for severe mitral regurgitation (MR)...
Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545Tobias Deuse
Transplant and Stem Cell Immunobiology Laboratory, University Heart Center Hamburg, Hamburg, Germany
Transplantation 94:695-702. 2012..This is the first report on the novel Janus kinase (JAK)1/3 inhibitors R507 and R545 for prevention of acute allograft rejection...
Transcatheter aortic valve implantation versus surgical aortic valve replacement: a propensity score analysis in patients at high surgical riskLenard Conradi
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
J Thorac Cardiovasc Surg 143:64-71. 2012..In this propensity-score analysis we compared outcomes after TAVI to those after surgical aortic valve replacement (AVR)...
Comparison of aortic root replacement in patients with Marfan syndromeAlexander M J Bernhardt
Department of Cardiovascular Surgery, University Heart Center, Hamburg, Germany
Eur J Cardiothorac Surg 40:1052-7. 2011....
Predictors of outcome of mitral valve prolapse in patients with the Marfan syndromeMeike Rybczynski
Centre of Cardiology and Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
Am J Cardiol 107:268-74. 2011..In conclusion, the same clinical determinants that predict outcomes in idiopathic mitral valve prolapse also predict outcomes in mitral valve prolapse associated with Marfan syndrome...
The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependentTobias Deuse
Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Transplantation 77:509-13. 2004..CONCLUSIONS: This study provides evidence that FK778 and tacrolimus show supportive interaction in their immunosuppressive potency that is synergistic in low-dose combinations and additive in higher doses...
First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary interventionLenard Conradi
Department of Cardiovascular Surgery, University Heart Center Hamburg, Martinistrasse 52, Hamburg, Germany
Clin Res Cardiol 100:311-6. 2011..We investigated our experience with combined transcatheter aortic valve implantation (TAVI) and percutaneous coronary intervention (PCI) as an alternative strategy in high-risk patients...
Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis. Up to 2-year follow-up of the direct-flow medical valve: a pilot studyKlaudija Bijuklic
Medical Care Center Prof Mathey, Prof Schofer, Hamburg University Cardiovascular Center, Hamburg University Heart Center, and Radiologische Allianz, Hamburg, Germany
Circ Cardiovasc Interv 4:595-601. 2011..We, therefore, analyzed the midterm stability of the position, shape, and hemodynamic performance of the DFM percutaneous aortic valve...
Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunctionOlaf Franzen
Department of General and Interventional Cardiology, University Heart Centre, Hamburg, Germany
Eur Heart J 31:1373-81. 2010..We sought to assess the feasibility of catheter-based mitral valve repair using the MitraClip system in high-surgical-risk patients with mitral regurgitation (MR) > or =grade 3+...
The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activitySonja Schrepfer
Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Martinistr, 52, 20246 Hamburg, Germany
Menopause 13:489-99. 2006....
Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantationHendrik Treede
Department of Cardiovascular Surgery, University Heart Center Hamburg, Martinistrasse 52, Hamburg, Germany
J Heart Lung Transplant 31:797-804. 2012..In this study we assessed the efficacy and safety of two de novo immunosuppression protocols to prevent BOS...
Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipientsSven Meyer
Department of General and Interventional Cardiology, University Heart Center, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Transplantation 91:1031-5. 2011..Vaccination against the novel influenza A (H1N1) virus has generally been advocated. There is limited experience with AS03-adjuvanted A/H1N1 pandemic influenza vaccines in immunosuppressed patients...
FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studiesTobias Deuse
Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Transplantation 78:71-7. 2004..CONCLUSION: Besides its inhibitory effect on pyrimidine synthesis, FK778 directly reduces endothelial adhesion molecule upregulation and attenuates lymphocyte-endothelium interaction, which is a critical step in graft rejection...
Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety studyJoachim Schofer
Medical Care Center Prof Mathey, Prof Schofer and Hamburg University Cardiovascular Center, University Heart Center Hamburg, Hamburg, Germany
Circ Cardiovasc Interv 1:126-33. 2008....
Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valveFariba Chalajour
Department of Cardiovascular Surgery, University Heart Center Hamburg, Martinistr 52, Hamburg, Germany
Exp Cell Res 313:2326-35. 2007..Hence, our findings might provide new insights into the process of pathological angiogenesis in cardiac valves...
Angiogenic activation of valvular endothelial cells in aortic valve stenosisFariba Chalajour
Department of Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
Exp Cell Res 298:455-64. 2004..These data provide new insights into the mechanisms of valvular disorders and open new perspectives for prevention and early treatment of calcified aortic stenosis...
Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experienceAli Aydin
Department of Electrophysiology, University Heart Center, Hamburg, Germany
Circ Arrhythm Electrophysiol 5:913-9. 2012..Recently, subcutaneous implantable cardioverter-defibrillator (S-ICD) has become available. The aim of our study was to assess the efficacy of S-ICD in a clinical setting...
Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?Tobias Deuse
University Heart Center Hamburg, Department of Cardiovascular Surgery, Martinistr 52, 20246, Hamburg, Germany
Transpl Immunol 17:255-61. 2007..Here we describe the techniques of heterotopic and orthotopic tracheal transplantations in the rat, comparing the kinetics of systemic host immune response and of histopathologic OAD development...
MitraClip® therapy in patients with end-stage systolic heart failureOlaf Franzen
Department of General and Interventional Cardiology, University Heart Centre, Hamburg, Germany
Eur J Heart Fail 13:569-76. 2011..To assess the feasibility, short-term durability and clinical outcomes of MitraClip® therapy for mitral regurgitation (MR) in patients with end-stage heart failure and a severely reduced left ventricular (LV) ejection fraction...
[3-year results of the SYNTAX trial--stent or surgery? A surgeon's perspective]Lenard Conradi
Klinik und Poliklinik für Herz und Gefäßchirurgie, Universitäres Herzzentrum Hamburg, Martinistrasse 52, Hamburg, Germany
Clin Res Cardiol Suppl 6:43-8. 2011..Final decision making should be a formal process as recommended in the recently updated guidelines on myocardial revascularization by the European Society of Cardiology...
Asymptomatic infection with novel influenza A/H1N1 virus in a heart transplant recipientSven Meyer
Department of General and Interventional Cardiology, University Heart Center, University Medical Center Hamburg Eppendorf, Hamburg, Germany
J Heart Lung Transplant 29:585-6. 2010..We present the first case of a young heart transplant recipient who remained asymptomatic despite positive polymerase chain reaction (PCR) after exposure to individuals with influenza A/H1N1...
Surgical technique of lower lobe lung transplantationTobias Deuse
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
Ann Thorac Surg 92:e39-42. 2011..Here we describe our surgical technique and discuss the benefits and risks of this procedure...
Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatmentEberhard Schulz
University Hospital Eppendorf, Division of Cardiology, Hamburg, Germany
Circulation 105:1170-5. 2002..CONCLUSIONS: We conclude that long-term NTG treatment induces endothelial dysfunction and impaired vascular NO/cGMP signaling in humans, which can be monitored by measuring P-VASP levels...
Evaluation of acute traumatic changes of the coronary artery wall after robotically assisted endoscopic coronary artery bypass graftingMartin Arnold
Department of Cardiac Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany
Heart Surg Forum 5:128-31. 2002..Goleta, CA) in a laboratory setting...
How to guide stent-graft implantation in type B aortic dissection? Comparison of angiography, transesophageal echocardiography, and intravascular ultrasoundDietmar H Koschyk
Department of Cardiology, University Hospital Hamburg Eppendorf, Hamburg, Germany
Circulation 112:I260-4. 2005..Despite growing interest in stent-graft implantation for type-B aortic dissection, there are no established recommendations to prepare and perform an implantation procedure...
Minimally invasive direct coronary artery bypass grafting (MIDCAB) and off-pump coronary artery bypass grafting (OPCAB): two techniques for beating heart surgeryChristian Detter
Department of Cardiac Surgery, University Hospital Grosshadern, Ludwig Maximilian University, Munich, Germany
Heart Surg Forum 5:157-62. 2002..Coronary bypass surgery can be performed less invasively by avoiding cardiopulmonary bypass (CPB). We present our experiences with beating heart bypass surgery performed through a minithoracotomy or sternotomy...
Robotically-assisted coronary artery surgery with and without cardiopulmonary bypass - from first clinical use to endoscopic operationChristian Detter
Department of Thoracic and Cardiovascular Surgery, University Hospital Grosshadern, Munich, Germany
Med Sci Monit 8:MT118-23. 2002..Recently, the ZEUS(tm) Robotic Surgical System has been introduced to increase the precision of endoscopic cardiac surgery. This study investigated its clinical use for endoscopic coronary artery bypass grafting...
Comparison of two stabilizer concepts for off-pump coronary artery bypass graftingChristian Detter
Department of Cardiac Surgery, University Hospital Grosshadern, Ludwig Maximilian University, Munich, Germany
Ann Thorac Surg 74:497-501. 2002..This study was designed to evaluate the efficacy of two different stabilizer concepts for off-pump coronary artery bypass grafting...
New technique for chest opening in mice: U-sternotomySonja Schrepfer
Department of Thoracic and Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
Microsurgery 23:274-5. 2003..This U-sternotomy reduces the risk of animal death and therefore the amount of quite expensive virus solutions needed...
Multidetector computed tomography (MDCT) in coronary surgery: first experiences with a new tool for diagnosis of coronary artery diseaseHendrik Treede
Department of Cardiac Surgery, Ludwig Maximilians University Munich, Germany
Ann Thorac Surg 74:S1398-402. 2002..Patients underwent CT scans in addition to SCA; findings were compared regarding location and degree of coronary artery stenosis...
Minimally invasive valve surgery: different techniques and approachesChristian Detter
Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
Expert Rev Cardiovasc Ther 2:239-51. 2004..This article will review the different minimally invasive techniques and approaches, as well as early results and outcomes for aortic and mitral valve surgery...
Experimental orthotopic tracheal transplantation: The Stanford techniqueSonja Schrepfer
Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305 5407, USA
Microsurgery 27:187-9. 2007..The technique is easy to learn, the procedure is well tolerated by the animals, and the grafts develop OAD lesions similar to those of human obliterative bronchiolitis...
Concomitant transcatheter aortic valve and left ventricular assist device implantationChristina Baum
University Heart Center Hamburg, 20246 Hamburg, Germany
ASAIO J 59:90-2. 2013..We believe concomitant transcatheter aortic valve implantation (TAVI) and LVAD implantation is a promising hybrid procedure, even in patients with pure AR...
Prospective, randomized study comparing two different minimized versus conventional cardiopulmonary bypass systemsJeannette Schoenebeck
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
Innovations (Phila) 5:270-7. 2010..We aimed to assess the impact of two different minimized cardiopulmonary bypass systems (mini-CPB) with and without Bioline-coating compared with CCPB regarding organ function, inflammatory response, and early clinical outcome...
Spontaneous coronary bypass ruptureJan Kaehler
Department of Cardiology, University Hospital Hamburg, Hamburg, Germany
Ann Thorac Surg 86:664. 2008
Fluorescent cardiac imaging: a novel intraoperative method for quantitative assessment of myocardial perfusion during graded coronary artery stenosisChristian Detter
Department of Cardiovascular Surgery, University Heart Center Hamburg, Martinistr 52, D 20246 Hamburg, Germany
Circulation 116:1007-14. 2007..FCI is a novel technology to visualize coronary vessels and myocardial perfusion intraoperatively using the indocyanine green dye with an infrared-sensitive imaging device...
Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failureSimon Pecha
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
Interact Cardiovasc Thorac Surg 15:922-3. 2012..We decided to proceed with CRT-D implantation while still on ECMO support. With biventricular stimulation, cardiac function improved promptly and the patient could be weaned from ECMO the same day...
Impact of AT2 receptor deficiency on postnatal cardiovascular developmentDaniel Biermann
Department of Cardiovascular Surgery, University Heart Center, Hamburg, Germany
PLoS ONE 7:e47916. 2012..The angiotensin II receptor subtype 2 (AT2 receptor) is ubiquitously and highly expressed in early postnatal life. However, its role in postnatal cardiac development remained unclear...
Use of initial biventricular mechanical support in a case of postinfarction ventricular septal rupture as a bridge to surgeryLenard Conradi
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
Ann Thorac Surg 87:e37-9. 2009..This approach may represent a new treatment option restoring hemodynamic stability and avoiding surgery on freshly infarcted myocardium...
Coincidence of aortic valve stenosis and regurgitation and multiple cardiac papillary fibroelastomas in a young male adultKarsten Sydow
Department of Cardiology, Hamburg University Heart Center, Hamburg, Germany
J Thorac Cardiovasc Surg 133:564-5. 2007
Vascular wall resident progenitor cells: a source for postnatal vasculogenesisElvin Zengin
Center of Experimental Medicine, Institute of Anatomy I, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Development 133:1543-51. 2006....
Gender effects on health care costs in cardiovascular medicine-a black box?Helmut Gulbins
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
Thorac Cardiovasc Surg 61:74-8. 2013..This manuscript deals with the possible economic implications of gender-related differences in cardiovascular medicine...
Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation modelTobias Deuse
Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Germany
Transplantation 76:1627-9. 2003..3 +/- 2.9 days; P<0.01; combination index=0.85). High-dose drug combination (mean survival time 24.0 +/- 1.4 days) showed antagonistic drug interaction (combination index=1.55) with increased toxic side effects...
Frequency and age-related course of mitral valve dysfunction in the Marfan syndromeMeike Rybczynski
Centre of Cardiology and Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany
Am J Cardiol 106:1048-53. 2010..006). In conclusion, MVP was comparatively frequent in patients with the Marfan syndrome and carries an increased risk of progression to severe MVR and endocarditis, especially in older adults...
Video and robotic-assisted minimally invasive mitral valve surgery: a comparison of the Port-Access and transthoracic clamp techniquesHermann Reichenspurner
Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Ann Thorac Surg 79:485-90; discussion 490-1. 2005..The MICRO technique tends to shorten the time of surgery and aortic cross-clamping and reduces perioperative costs by simplifying the operative procedure...
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillationVolker Rudolph
1Department of General and Interventional Cardiology and Cardiovascular Research Center, University Heart Center, Hamburg, Germany
Nat Med 16:470-4. 2010..Our data demonstrate that MPO is a crucial prerequisite for structural remodeling of the myocardium, leading to an increased vulnerability to atrial fibrillation...
Which patients benefit from stentless aortic valve replacement?Helmut Gulbins
Department of Cardiovascular Surgery, University Heart Center, University Hospital Eppendorf, Hamburg, Germany
Ann Thorac Surg 88:2061-8. 2009..Jude Medical, Minneapolis, MN) showed an increase in degeneration after 10 years of follow-up, whereas the Freestyle porcine stentless prostheses (Medtronic, Minneapolis, MN) still showed excellent results after this period...
The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signalingMichael Grimm
Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, Hamburg, Germany
Br J Pharmacol 148:991-1000. 2006....
Successful resection of a symptomatic right ventricular lipomaSonja Schrepfer
Department of Cardiovascular Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany
Ann Thorac Surg 76:1305-7. 2003..Histology confirmed diagnosis of a benign cardiac lipoma. The postoperative course was uneventful and the patient was discharged 7 days after surgery. There was no episode of ventricular tachycardias during the 6-month follow-up...
Robotically assisted coronary artery bypass surgery with the ZEUS telemanipulator systemDieter H Boehm
Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Semin Thorac Cardiovasc Surg 15:112-20. 2003..This article summarizes the current worldwide experience with the ZEUS(TM) system in cardiac surgery and describes the steps from preclinical to endoscopic operation, focusing on the potential limitations of the procedure and the system...
Stent-based approach for ventricle-to-coronary artery bypassPeter Boekstegers
Department of Internal Medicine I, Grosshadern University Hospital, Munich, Germany
Circulation 106:1000-6. 2002..Ventricle-to-coronary artery bypass (VCAB) is an experimental revascularization procedure that provides predominantly systolic instead of diastolic blood flow to a coronary artery...
Myoblasts survive intracardiac transfer and divide further after transplantationHelmut Gulbins
Department of Cardiac Surgery, University Hospital Grosshadern, LMU Munich, D 81366 Munich, Germany
Heart Surg Forum 5:340-4. 2002..In addition, an intravital fluorescence dye for marking these cells was evaluated...
Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trialAndreas Zuckermann
Department of Cardiothoracic Surgery, University of Vienna, Austria
J Thorac Cardiovasc Surg 125:891-900. 2003..Benefit or risk deriving from the combination with mycophenolate mofetil are yet unknown...
Early and midterm results after coronary artery bypass grafting with and without cardiopulmonary bypass: which patient population benefits the most?Tobias Deuse
Department of Cardiac Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Germany
Heart Surg Forum 6:77-83. 2003..We present our early and midterm results with off-pump coronary artery bypass grafting (OPCAB) on the beating heart and with conventional coronary artery bypass grafting (CABG) and compare patient outcomes for both procedures...
Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I studyTilmann Pohl
Department of Internal Medicine I, Grosshadern University Hospital, Munich, Germany
Catheter Cardiovasc Interv 62:323-30. 2004....
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejectionKambiz Sarahrudi
Department of Cardithoracic Surgery, University of Vienna, Austria
J Thorac Cardiovasc Surg 127:1126-32. 2004..Conversion for bronchiolitis obliterans syndrome allows short-term stabilization of lung function in most patients...
[Mitral valve reconstruction without cardiopulmonary bypass. Border zone between cardiac surgery and interventional cardiology]Thilo Tübler
Universitäres Herz und Gefässzentrum Hamburg GmbH, Hamburg
Herz 31:406-12. 2006..In this article, the authors focus on the available data as well as on the advantages and disadvantages of the different approaches...
Review on balloon aortic valvuloplasty: a surgeon's perspective in 2008Lenard Conradi
Clin Res Cardiol 97:285-7. 2008..In the rare case of real contraindications to surgical AVR transcatheter valve implantation techniques seem to be the more adequate alternative today...
Improved results after heart-lung transplantation: a 17-year experienceBruno Reichart
Department of Cardiac Surgery, University Hospital Grosshadern, Ludwigs-Maximilians-University, Munich, Germany
Transplantation 75:127-32. 2003..Long-term results can only be improved in cases of successful prevention and treatment of OB...
Diagnosis of perioperative myocardial infarction after coronary artery bypass surgeryHermann Reichenspurner
Herz 29:656-7. 2004
[Myoblasts from the leg into the heart: can infarct damage be rectified in this manner? (interview by Dr. Judith Neumaier)]Hermann Reichenspurner
MMW Fortschr Med 147:22. 2005
Heart transplantation: an approach to treating primary cardiac sarcoma?Peter Uberfuhr
Division of Cardiac Surgery, Klinikum Grosshadern, University of Munich, Munich, Germany
J Heart Lung Transplant 21:1135-9. 2002..However, pre-operative chemotherapy can regress tumors in chemosensitive C-STS and potentially eradicate early micrometastases. Consecutive HTx for responders may then offer a chance of long-term survival...
The Cardica C-Port System: clinical and angiographic evaluation of a new device for automated, compliant distal anastomoses in coronary artery bypass grafting surgery--a multicenter prospective clinical trialKlaus E Matschke
Department of Cardiac Surgery, University of Technology Dresden, Dresden, Germany
J Thorac Cardiovasc Surg 130:1645-52. 2005..The goal of this prospective, nonrandomized, and multicenter study is to determine the safety and efficacy of this novel anastomotic system...
Introducing the first polymer-free leflunomide eluting stentTobias Deuse
Department of Cardiothoracic Surgery, Stanford University School of Medicine, 300 Pasteur Dr, CVRB MC 5407, Stanford, CA, USA
Atherosclerosis 200:126-34. 2008..We here describe the pharmacological characteristic, in vivo efficacy, and in vitro mechanisms of a polymer-free leflunomide eluting stent in comparison to its rapamycin-coated equivalent...
